Articles, App Notes, Case Studies, & White Papers

1. The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets 10/4/2024

   Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.

2. Using IRT Data To Automate And Optimize Clinical Supply 4/17/2023

   Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.

3. Benefits Of Electronic Labels: Investigational Medicinal Products 12/2/2022

   When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.

4. Key Considerations For Labeling Your Cell Or Gene Therapy

   As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.

5. IRT? RTSM? What's The Difference? 10/4/2024

   What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?

6. From Frustration To Organization: An SSO Platform For Trial Sites 5/2/2025

   To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.

7. Investigational Medicinal Products: Labeling Changes And Their Implications 12/16/2022

   Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.

8. How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution 9/20/2021

   Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.

9. Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial 3/9/2026

   Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.

10. Outsourcers Are Feeling Uneasy About Continuity Of Supply 4/14/2022

    Find out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.